Zhiding Medical Secures Nearly RMB 100 Million Series C Funding to Advance Ophthalmic Diagnostic Innovations

Recently,ZhiDing Medical Technology (Hang Zhou) Co.,Ltd(abbreviation: ZD Medical)Successfully CompletedNearly 100 Million C-round Financing。This round of financingThe investment was led by Taipu Life Science Investment, with active participation from Hanking Capital, Huiding Capital, Mifang Capital, and Yangyun Capital.CompanyIn the third quarter of 2022Completed a 50 million B-round financing. The investment funds will mainlyFor the company's new product development, new market expansion, and development channel construction.。

As of the date of publication,The company has completed 4 rounds of financing, with a total of 8 products approved for marketing in China., including optical coherence tomography (OCT) for ophthalmology, dry eye tester, ophthalmic microscopic image analyzer, medical ultrasonic nebulizer, and ophthalmic imaging storage and transmission software.

# Introduction to Core Products

Full-process Intelligent Diagnosis OCT

Luminor-D60/D60M

The series of OCT products haveFast Scanning and ImagingThe ability to acquire high-quality fundus images in a short period of time, truly reflecting the subtle structures of the fundus tissue, andEquipped with professional analysis software, it can analyze scan data, helping doctors quickly and accurately identify lesion locations, improving diagnostic efficiency and accuracy, includingDiagnosis of macular diseases, glaucoma analysis, and anterior segment diagnosis, etc.。

Blood Flow Imaging OCT is aNon-invasive, Non-contact, High-resolutionTomographic imaging equipment, used forTomographic imaging and examination of the fundus tissue structure, including the retina, macula, and optic disc, is an auxiliary diagnostic device, including but not limited to diabetic retinopathy, age-related macular degeneration, central retinal vein occlusion, branch retinal vein occlusion, idiopathic, CNV, glaucoma.

Overall Solution for Dry Eye

• Tear Meniscus Height Measurement: Precise measurement of 0.01mm, combined with exclusive area zoom technology and the maximum three-time average value, can detect more accurate data;
• Tear Film Break-Up Time Assessment: Exclusive multi-measurement and anti-error technology for precise evaluation of tear film break-up time and area;
• Lipid Layer Assessment: Utilizing the principle of birefringent light interference, it rapidly captures interferometric images and video recordings of the tear film during the blink, allowing for a graded assessment of lipid layer quality.
• Meibomian Gland Examination: Image algorithm enhancement contrast, capable of quantitatively analyzing meibomian gland dropout and grading its severity.

# About ZD Medical

ZhiDing Medical Technology (Hang Zhou) Co., Ltd was founded in 2015, with its headquarters located in Hangzhou. It is a high-tech enterprise specializing in the research, development, production, and sales of high-precision ophthalmic optical medical devices, established by several overseas returnee doctors. The company owns an American optical research and development center and has formed an international team dedicated to product research and industrial conversion technology, focusing on the development and innovation of new products.

As of the date of publication, the company's financing history is as follows:

As of the date of publication, the following partial patent information of the company has been queried: